Navidea Biopharmaceuticals Inc Market cap
What is the Market cap of Navidea Biopharmaceuticals Inc?
The Market cap of Navidea Biopharmaceuticals Inc is $9.71M
What is the definition of Market cap?
Market capitalization is the market value at a point in time of the shares outstanding of a publicly traded company, being equal to the share price at that point of time times the number of shares outstanding.
= outstanding shares * previous day’s close
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Market cap of companies in the Health Care sector on NYSEMKT compared to Navidea Biopharmaceuticals Inc
What does Navidea Biopharmaceuticals Inc do?
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Companies with market cap similar to Navidea Biopharmaceuticals Inc
- Botswana Diamonds plc has Market cap of $9.69M
- Softimat S.A has Market cap of $9.69M
- China Automotive Interior Decoration has Market cap of $9.69M
- Zhuoxin International has Market cap of $9.69M
- Lamtex has Market cap of $9.70M
- Chakana Copper has Market cap of $9.70M
- Navidea Biopharmaceuticals Inc has Market cap of $9.71M
- Pittards plc has Market cap of $9.71M
- Surge Exploration has Market cap of $9.71M
- Deson Development International has Market cap of $9.72M
- Golden Arrow Resources has Market cap of $9.72M
- Lee Hing Development has Market cap of $9.72M
- Guardion Health Sciences Inc has Market cap of $9.73M